GENESCIENCE PHARMACEUTICALS
GeneScience Pharmaceuticals manufactures recombinant human growth hormone. Its branding product includes GenLei and Jintropin. The company was founded in 1996 and is headquartered in China. Its manufacturing facility covers more than 20,000 sq.m. of land with 11,000 sq.m. of production area.
GENESCIENCE PHARMACEUTICALS
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Euro PHP Pound Sterling Japanese Yen Shockwave Flash Embed
Similar Organizations
Popular Pharmaceuticals
Popular Pharmaceuticals is the manufacturer of Human Insulin in Bangladesh.
Qubit Pharmaceuticals
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-02-07 | Rani Therapeutics | GeneScience Pharmaceuticals investment in Venture Round - Rani Therapeutics | 53 M USD |
More informations about "GeneScience Pharmaceuticals"
Changchun GeneScience Pharmaceutical Co., Ltd._Pediatric Health …
Changchun GeneScience Pharmaceuticals Co., Ltd. (“GenSci”), founded in 1996, is a subsidiary of Changchun High-Tech Industries (Group) Co., Ltd (stock code 000661). Its administrative headquarters and manufacturing sites are located in Changchun, the capital of Jilin Province; …See details»
GeneScience Pharmaceuticals - Crunchbase
GeneScience Pharmaceuticals manufactures recombinant human growth hormone. Its branding product includes GenLei and Jintropin. The company was founded in 1996 and is …See details»
GeneScience Pharmaceuticals Co., Ltd. - VentureRadar
Changchun GeneScience Pharmaceutical Co., Ltd., also known as GenSci, is a biopharmaceutical company that specializes in pediatric health, wound healing, and female …See details»
Changchun Genescience Pharmaceuticals Co., Ltd.
Mar 7, 2025 Explore Changchun Genescience Pharmaceuticals Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 149 clinical trials, 1 news, and 17 literature, Disease …See details»
GeneScience Pharmaceuticals Co. - PitchBook
Sep 27, 2005 GeneScience Pharmaceuticals Co. General Information Description. Manufacturer of biopharmaceutical drugs based in Changchun, China. The company offers a range of products including somatropin …See details»
GeneScience Pharmaceuticals Company Profile - Office Locations …
See insights on GeneScience Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Organization | GeneScience Pharmaceuticals Co., Ltd. - Purdue …
Organization Overview. First Clinical Trial. 2006 NCT01342146. First Marketed Drug. None First NDA Approval. None ... GeneScience Pharmaceuticals Co., Ltd. Active Ingredients. Drugs in …See details»
R&D -Changchun GeneScience …
GenSci takes the lead in the fields of children's and women's health, demonstrating an unwavering commitment to providing holistic health management throughout the life cycle.Our …See details»
GeneScience Pharmaceuticals Co Ltd DMF, CEP, Written
GeneScience Pharmaceuticals Co Ltd// GeneScience Pharmaceuticals Co., Ltd. (GenSci), was established in 1996. GenSci\'s production facility is located in one of the top 6 national …See details»
GenSci Launches Global Innovation Hub in Shanghai
SHANGHAI, Dec. 22, 2023 /PRNewswire/ -- Changchun GeneScience Pharmaceutical ("GenSci"), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking ceremony for its new global headquarters and …See details»
GeneScience Pharmaceuticals - Investments, Portfolio & Company …
GeneScience Pharmaceuticals has invested in Rani Therapeutics on Feb 7, 2018. This investment - Venture Round - Rani Therapeutics - was valued at . obfuscated. obfuscated. …See details»
GenSci Showcases the Latest R&D Achievements at J.P. Morgan
Oct 25, 2024 Recently, Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci) showcased its series of innovative pipelines at the 43rd Annual J.P. Morgan Healthcare Conference. Xia …See details»
About GeneScience Pharmaceuticals Co., Ltd.. - CPHI Online
GeneScience Pharmaceuticals Co., Ltd. Address 1718 Yueda Road, Changchun High-Tech Development Zone, 130012, Jilin, China Telephone +86(431)8519-5060 Website …See details»
Somatropin pegylated - GeneScience Pharmaceuticals
04 Feb 2025 Changchun GeneScience Pharmaceutical plans a phase I bioequivalence trial for Somatotrophin deficiency (In Volunteers) in China (SC, Injection) in February 2025 …See details»
NMPA Approves the PD-1 agonist GenSci120 for Clinical Trials ...
On January 15, 2025, Changchun GeneScience Pharmaceutical Co., Ltd. (GenSci) received approval from the National Medical Products Administration (NMPA) for its independently …See details»
GenSci122 - Drug Targets, Indications, Patents - Synapse
Evaluate the safety and tolerability of GenSci122 in subjects with advanced solid tumors to determine the maximum tolerated dose and recommended dose for the extension phase; …See details»
GenSci Launches Global Innovation Hub in Shanghai - BioSpace
SHANGHAI, Dec. 22, 2023 /PRNewswire/ -- Changchun GeneScience Pharmaceutical ("GenSci"), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking …See details»
GS-P-328 - Drug Targets, Indications, Patents - Synapse - Patsnap
Apr 19, 2025 Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»
GenSci' s Inaugural R&D Day 2024: Innovation in Gene, Science in …
Over 100 industry experts, including senior executives from Changchun High-Tech Industry (Group) and GenSci, R&D and business development leaders from multinational …See details»